AzTrials
AzTrials

Cholesterol, LDLNCT04841460

Impact of Beef's Unique Food Matrix on Human Health

A study testing Low-fat ground beef and High-fat ground beef in people with Cholesterol, LDL and Cholesterol, HDL, run by Texas A&M University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. Read more about this study

Who is it for?
Any age, men onlyHealthy volunteers can take part
What is being tested?
Low-fat ground beef and High-fat ground beef
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteUnited States
Study dates
18 Feb 2019to 30 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • The participants will be male and not have had total cholesterol above 300 mg/dL or below 120 mg/dL.

Who cannot join

  • The participants will be male and must not have been consuming restrictive diets or cholesterol-lowering medications.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas A&M University

    College Station, Texas, 77843

Other trials in United States

About this study

Official title: Impact of Beef's Unique Food Matrix on Human Health - Cholesterol Metabolism and Voluntary Nutrient Intake in Men Consuming Low-fat and High-fat Ground Beef

The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that increasing the amount of fat in ground beef reduces risk factors for cardiovascular disease. Also, the investigators will measure changes in glucose, insulin, and triacylglycerols (TAG) following low-fat and high-fat ground beef interventions. An important aspect of this research is that the investigators will confirm that consumption of high-fat ground beef will reduce carbohydrate intake and increase insulin sensitivity in men. Furthermore, the investigators will be able to establish which protein sources are voluntarily replaced by the low- and high-fat ground beefs.

Read the detailed description

Healthy, non-smoking males will be screened for eligibility, and a minimum of 30 males will be selected for the study based primarily on plasma low-density lipoprotein cholesterol (LDL-C) concentrations but also on plasma TAG concentrations. The men must not be consuming restrictive diets or cholesterol-lowering medications, and must not have total cholesterol above 300 mg/dL or below 120 mg/dL. Participants will be requested not to change their habitual level of physical activity. Plasma TAG should not exceed 220 mg/dL. A two-period, randomized cross-over design will be used based on previous studies from our laboratory. Each participant will complete two, 5-week ground beef interventions in a randomly assigned order with a 4-week washout period between the test periods. The men will consume 5 ground beef patties per week for 5 weeks for each ground beef type (25 patties for each type). The two treatments will be low-fat (5% fat) and high-fat (25% fat) ground beef. Participants will be assigned to one of two groups (n ≥ 15 per group), which will be balanced with regard to LDL-C concentrations at the initial screening. The groups will be blocked for age and body weight.

Visit 1 for the subjects selected for the study (immediately before the first dietary intervention) (about 1 hour):

The Registered Dietitian will provide diet instructions, sample menus and cooking instructions. Participants will receive instructions for completion of the diet records using the NutriBase software.

Participants will receive the first set of patties. Subjects will complete a 3-day diet record in NutriBase (which is done at home) before they begin eating the patties. Instructions will also be provided to subjects regarding schedule of patty consumption.

Subjects will complete a 3-day diet record in NutriBase during week 5 of the patty consumption.

The Registered Dietitian or Principal Investigator will contact the study subjects (phone or email) once weekly to ask if the subjects have any questions about the study or the NutriBase system, and ensure they are cooking and using the patties as instructed.

After the initial 5 week intervention, there is a 4 week washout period where subjects will have no study visits and will eat their regular diet. Subjects will be asked to continue complete a 3-day diet record in NutriBase during the last week of the washout period.

The Registered Dietitian or PI will contact the study subjects (phone or email) once weekly to ask if the subjects have any questions about the study or the NutriBase system, and ensure the subjects are cooking and using the patties as instructed.

Source of ground beef. The source of raw materials for production of the 5 and 25% fat patties will be flank and plate primals from feedlot-fed cattle processed through the Rosenthal Meat Science and Technology Center, Texas A\&M University. Primals will be selected from grain-fed cattle finished under typical feedlot condition, fed at the Texas A\&M University O.D. Butler Animal Science Teaching and Research Center. Prior to the initiation of each phase of the ground beef interventions, each participant will receive an unlabeled box containing 25 frozen, vacuum packaged patties.

Participants will be trained extensively in the preparation and consumption of the ground beef patties. The Registered Dietitian is an individual consultant who will provide professional input regarding cooking methods and diet record keeping to the subjects. The investigators predict that, under conditions in which energy intake remains constant, the percent energy from fat consumed by the participants will increase while the percent energy from carbohydrates will decrease.

Dietary guidelines and diet records. All participants will receive instructions from an Registered Dietitian for the preparation and consumption of the ground beef, including recipes; the Registered Dietitian also will contact the participants as indicated in the study visits above. Other than the patty consumption, subjects will be told to eat their regular diet. Previous studies of the investigators indicated strong compliance to consumption of the ground beef patties, and indicated no changes to the habitual diets of the participants other than a reduction in the percent of calories from carbohydrates.

For the screening visit, participants will be required to visit the Department of Animal Science for a detailed overview of study, including the goals and anticipated outcomes and collect the vital measurements and blood to determine eligibility.

For visit 1, The study staff will explain the Nutribase software and give detailed instructions for the diet records. The Registered Dietitian will provide instruction and suggestions for recipes, and will emphasize the importance of consuming the test ground at the prescribed intervals. During the course of the two, 5-week test periods, the Registered Dietitian or PI will contact the participants at weekly intervals to answer any questions about the completion of the diet records or beef preparation.

Participants will be asked to complete a 3-day diet record during the week before the diet interventions and during the last week of each intervention to establish nutrient intakes and encourage compliance. The NutriBase software is relatively simple to use and will allow more accurate information about dietary intakes. Daily intake of protein, carbohydrates, and fat will be analyzed using commercial NutriBase software. Diet software used in the previous studies of the investigators provided information about lean, medium-fat, and high-fat meat consumption, but did not allow the investigators to determine which meat sources were being replaced by the test ground beef patties; replacement of customary meat sources (e.g., fish, pork, or poultry) by the test patties will be documented in the current study. Additionally, dietary exchanges (meats, breads, fruit, vegetables, etc.) will be analyzed to document the predicted reduction in carbohydrate intake during the consumption of the test patties.

General blood sampling and analyses. On the days of blood sampling, subjects will be asked to report to the laboratory after an overnight fast (at least 10 hours) restricted to water only. Blood (10 mL) will be collected after 5 minutes of seated rest via venipuncture from the antecubital fossa region into serum separator vacutainer tubes using standard, sterile phlebotomy procedures. Blood samples will be drawn during the screening visit and at visits 2, 3, and 4. A total of approximately 40 mL blood will be drawn from each participant over approximately 15 weeks.

After collection, blood will be allowed to clot at room temperature for 2 hours or chilled at 4°C for serum and plasma separation, respectively, prior to centrifugation in a refrigerated centrifuge for 20 minutes (2,000 × g). One serum separator vacutainer will be transported the same day to a commercial, Clinical Laboratory Improvement Amendments (CLIA) certified laboratory for determination of total cholesterol, HDL-C, LDL-C, and TAG using standard clinical chemistry analyses. Aliquots of serum and plasma from additional vacutainers will be transferred into separate 2-mL freezer vials.

Lipoprotein particle number determination. Lipoprotein particle mass area under the curve will be determined with a continuous gradient generated by analytical ultracentrifugation. This procedure allows for the determination at their specific densities of the total number of particles of very low-density lipoprotein (VLDL), LDL, dense LDL-III, dense LDL-V, HDL, buoyant HDL-2b, and remnant lipoprotein (RLP). The concentrations of LDL-I plus LDL-II can be calculated by difference.

Statistical analyses. Because all subjects will be rotated through both ground beef interventions, the data will be analyzed by a split plot design, with diet as the whole plot and time (habitual diet vs test diet) as the split plot. Power calculations were conducted to estimate the required sample size on the basis of data from our previous studies in which HDL-C was increased 2.8 mg/dL by consumption of 24% fat ground beef compared to habitual diets. Analyses used the following assumptions: power was set at 0.8, and a was set at 0.05. It was estimated that a sample size of 16 was sufficient to test the hypothesis that high-fat ground beef would increase HDL-C concentrations.

Being tested
Low-fat ground beef, High-fat ground beef

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-fat ground beefDietary supplement

    5% fat ground beef

  • High-fat ground beefDietary supplement

    25% fat ground beef

Study groups in NCT04841460
Study groupRoleWhat they receive
Low-fat ground beefExperimentalParticipants will consume 25 low-fat ground beef patties, 5 patties per week for 5 weeks.
Receives: Dietary Supplement: Low-fat ground beef
High-fat ground beefExperimentalParticipants will consume 25 high-fat ground beef patties, 5 patties per week for 5 weeks.
Receives: Dietary Supplement: High-fat ground beef

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lipoprotein cholesterol

    Lipoprotein cholesterol concentrations and density distributions

    Measured: 10 weeks

Secondary outcomes (2)
  1. Dietary intake

    Percent energy from protein, carbohydrate, and fat

    Measured: 10 weeks

  2. Body mass index

    Body weight in kilograms and height in meters will be measured to calculate body mass index

    Measured: 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2021
  2. Study start18 Feb 2019
  3. Primary completion19 Jul 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
The study design is a two-period, randomized crossover design.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04841460
Sponsor's protocol ID
IRB2018-0755D
Status last verified
Apr 2021
First submitted
9 Mar 2021
Last updated
12 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data may be shared with the funding agency.

Publications

  • Gilmore LA, Walzem RL, Crouse SF, Smith DR, Adams TH, Vaidyanathan V, Cao X, Smith SB. Consumption of high-oleic acid ground beef increases HDL-cholesterol concentration but both high- and low-oleic acid ground beef decrease HDL particle diameter in normocholesterolemic men. J Nutr. 2011 Jun;141(6):1188-94. doi: 10.3945/jn.110.136085. Epub 2011 Apr 27.

    PubMed 21525253

Questions about this trial

What is this clinical trial studying?

A study testing Low-fat ground beef and High-fat ground beef in people with Cholesterol, LDL and Cholesterol, HDL, run by Texas A&M University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lipoprotein cholesterol (time frame: 10 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04841460, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in